TrialInvestigational new drugs2015

A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia.

Olatoyosi Odenike et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.